{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:39:37Z","timestamp":1761766777469,"version":"3.40.5"},"reference-count":35,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s260887","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:57:22Z","timestamp":1600981042000},"page":"3915-3927","source":"Crossref","is-referenced-by-count":3,"title":["&lt;p&gt;Antiemetic Prophylaxis with Fosaprepitant and 5-HT&lt;sub&gt;3&lt;\/sub&gt;-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation&lt;\/p&gt;"],"prefix":"10.2147","volume":"Volume 14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-9159","authenticated-orcid":true,"given":"Karin Melanie","family":"Cabanillas Stanchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semjon","family":"Willier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Vek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-1846","authenticated-orcid":true,"given":"Manon","family":"Queudeville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-7837","authenticated-orcid":true,"given":"Nora","family":"Rieflin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-7790","authenticated-orcid":true,"given":"Veronika","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7500-5987","authenticated-orcid":true,"given":"Melanie","family":"Gansel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim Vincent","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Flaadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8517-9681","authenticated-orcid":true,"given":"Tobias","family":"Feuchtinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Handgretinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8134-7350","authenticated-orcid":true,"given":"Michaela","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pcl.2010.01.001","volume":"57","author":"Barrett","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1586\/14737140.5.5.835","volume":"5","author":"Hale","year":"2005","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref3","first-page":"Cd008216","volume":"4","author":"Peinemann","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","first-page":"Cd006301","volume":"10","author":"Yalcin","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1398-2265.2004.00202.x","volume":"8","author":"Gardner","year":"2004","journal-title":"Pediatr Transplant"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-015-1904-0","volume":"126","author":"Schrey","year":"2016","journal-title":"J Neurooncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S1470-2045(14)70336-5","volume":"15","author":"de Jong","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1023\/a:1026539908115","volume":"11","author":"Burdach","year":"2000","journal-title":"Ann Oncol"},{"key":"ref9","unstructured":"P\u00e4diatrische Arbeitsgemeinschaft f\u00fcr Stammzelltransplantation und Zelltherapie (PAS&ZT) Deutschland. Kooperatives P\u00e4diatrisches Register f\u00fcr Stammzell Transplantationen der P\u00e4diatrischen Arbeitsgemeinschaft - Bericht 2017\/2018; 2019 [updated April 2, 2019]. Available from: http:\/\/www.drst.de\/drst\/download\/prst_jb2017_2018.pdf. Accessed April 25, 2020."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/bmt.2017.112","volume":"52","author":"Flank","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.bmt.1703579","volume":"30","author":"Kusnierczyk","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"ref12","unstructured":"European Medicines Agency (EMA) - Committee for Medicinal Products for Human Use (CHMP). Assessment report Ivemend - Procedure No. EMEA\/H\/C\/000743\/II\/0037; 2018. Available from: https:\/\/www.ema.europa.eu\/documents\/variation-report\/ivemend-h-c-743-ii-0037-epar-assessment-report-variation_en.pdf. Accessed December 12, 2018."},{"key":"ref13","unstructured":"US Food and Drug Administration. EMEND - Fosaprepitant Dimeglumine. NDA 022023 - SUPPL-17. SUPPL-17 Web site; 2018. Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/UCM605696.pdf. Accessed December 12, 2018."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00520-016-3384-y","volume":"25","author":"Dupuis","year":"2017","journal-title":"Support Care Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e26542","DOI":"10.1002\/pbc.26542","volume":"64","author":"Patel","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1634\/theoncologist.2014-0229","volume":"20","author":"Aapro","year":"2015","journal-title":"Oncologist"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.2147\/DDDT.S214264","volume":"13","author":"Cabanillas Stanchi","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00432-020-03143-8","volume":"146","author":"Cabanillas Stanchi","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2147\/PPA.S31288","volume":"7","author":"Celio","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/1078155215585190","volume":"22","author":"Clark","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.bbmt.2018.06.005","volume":"24","author":"Clemmons","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S282","DOI":"10.1016\/j.bbmt.2010.12.389","volume":"17","author":"Duquette","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1186\/s12885-019-6252-6","volume":"19","author":"Willier","year":"2019","journal-title":"BMC Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/pbc.23114","volume":"57","author":"Dupuis","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref25","unstructured":"U.S. NIH -NCI. Common terminology criteria for adverse events v4.03 (CTCAE) 2010. May 28, 2009; 2010."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/bcp.13322","volume":"83","author":"Patel","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.clml.2017.06.012","volume":"17","author":"Trifilio","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref28","first-page":"e27551","author":"Radhakrishnan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ped.13780","volume":"61","author":"Saito","year":"2019","journal-title":"Pediatr Int"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5863\/1551-6776-19.2.127","volume":"19","author":"Shillingburg","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MPH.0000000000001213","volume":"40","author":"Timaeus","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S1083-8791(99)70015-7","volume":"5","author":"Orchard","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bmt.1704714","volume":"34","author":"Walsh","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1053\/bbmt.2001.v7.pm11760147","volume":"7","author":"Fox-Geiman","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1592\/phco.26.9.1221","volume":"26","author":"Dupuis","year":"2006","journal-title":"Pharmacotherapy"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61778","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61778","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:57:29Z","timestamp":1600981049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/antiemetic-prophylaxis-with-fosaprepitant-and-5-ht3-receptor-antagonis-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2147\/dddt.s260887","relation":{},"ISSN":["1177-8881"],"issn-type":[{"type":"electronic","value":"1177-8881"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}